Harvard Innovation Labs

Harvard Innovation Labs Stories: Michael Schrader - Vaxess Technologies

03.08.2017 - By Harvard Innovation LabsPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

When the i-lab first opened in 2011, Vaxess Technologies, a company co-founded and led by Michael Schrader, was one of the handful of ventures that consistently showed up to work out of the new space. Last year, after a short stint at LabCentral, Schrader and Vaxess returned to Harvard's "innovation campus" on Western Avenue in Allston as part of the Pagliuca Harvard Life Lab.

Vaxess, which, had received about $6M in funding, grants, and awards combined, recently announced that it had received another $6 million grant, this time from the Gates Foundation, in order to continue developing its silk biopolymer technology and to take its innovative vaccine delivery system to clinical trials.

This is a Harvard Innovation Labs Story.

More episodes from Harvard Innovation Labs